Search alternatives:
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
941
Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension.
Published 2012“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”
-
942
-
943
Decrease in extracellular Zn<sup>2+</sup> in the hippocampus by zinc chelators.
Published 2013“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”
-
944
N100 amplitude decrease during 1 Hz-rTMS.
Published 2013“…<p>(<b>A</b>) N100 amplitude reduction during 1 Hz-rTMS (group mean values). …”
-
945
-
946
-
947
-
948
-
949
-
950
Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice.
Published 2019“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”
-
951
Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro.
Published 2009“…(E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”
-
952
-
953
-
954
-
955
-
956
-
957
-
958
-
959
-
960
Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity.
Published 2015“…<p>A) Dose-dependent decrease of Infections per field of view (y-axis) after treatment of FHs 74 Int cells with increasing concentrations of the SHP-2-specific inhibitor, SHP-2 PTPase Inhibitor. …”